285 related articles for article (PubMed ID: 9516935)
41. Bcl-2 inhibitors induce apoptosis in chronic lymphocytic leukemia cells.
Campàs C; Cosialls AM; Barragán M; Iglesias-Serret D; Santidrián AF; Coll-Mulet L; de Frias M; Domingo A; Pons G; Gil J
Exp Hematol; 2006 Dec; 34(12):1663-9. PubMed ID: 17157163
[TBL] [Abstract][Full Text] [Related]
42. In vitro induction of apoptosis of neoplastic cells in low-grade non-Hodgkin's lymphomas using combinations of established cytotoxic drugs with bendamustine.
Chow KU; Boehrer S; Geduldig K; Krapohl A; Hoelzer D; Mitrou PS; Weidmann E
Haematologica; 2001 May; 86(5):485-93. PubMed ID: 11410411
[TBL] [Abstract][Full Text] [Related]
43. Bryostatin-1 enhances the maturation and antigen-presenting ability of murine and human dendritic cells.
Do Y; Hegde VL; Nagarkatti PS; Nagarkatti M
Cancer Res; 2004 Sep; 64(18):6756-65. PubMed ID: 15374994
[TBL] [Abstract][Full Text] [Related]
44. Precursor frequency analysis of bryostatin activated lymphocytes.
Fleming MD; Barrett SK; Bear HD
J Surg Res; 1994 Jul; 57(1):74-9. PubMed ID: 8041153
[TBL] [Abstract][Full Text] [Related]
45. Benzylamide sulindac analogues induce changes in cell shape, loss of microtubules and G(2)-M arrest in a chronic lymphocytic leukemia (CLL) cell line and apoptosis in primary CLL cells.
Moon EY; Lerner A
Cancer Res; 2002 Oct; 62(20):5711-9. PubMed ID: 12384529
[TBL] [Abstract][Full Text] [Related]
46. 2-Chlorodeoxyadenosine (2-CdA) in the treatment of patients with relapsed chronic lymphocytic leukemia.
Krykowski E; Warzocha K; Robak T
Arch Immunol Ther Exp (Warsz); 1995; 43(5-6):317-21. PubMed ID: 8744653
[TBL] [Abstract][Full Text] [Related]
47. Preclinical evaluation of bryostatin as an anticancer agent against several murine tumor cell lines: in vitro versus in vivo activity.
Hornung RL; Pearson JW; Beckwith M; Longo DL
Cancer Res; 1992 Jan; 52(1):101-7. PubMed ID: 1727368
[TBL] [Abstract][Full Text] [Related]
48. Comparison of antitumor activities of 2-chlorodeoxyadenosine and 9-beta-arabinosyl-2-fluoroadenine in chronic lymphocytic leukemia and marrow cells in vitro.
Begleiter A; Verburg L; Ashique A; Lee K; Israels LG; Mowat MR; Johnston JB
Leukemia; 1995 Nov; 9(11):1875-81. PubMed ID: 7475278
[TBL] [Abstract][Full Text] [Related]
49. Engraftment of human chronic lymphocytic leukemia cells in SCID mice: in vivo and in vitro studies.
Hummel JL; Lichty BD; Reis M; Dubé I; Kamel-Reid S
Leukemia; 1996 Aug; 10(8):1370-6. PubMed ID: 8709647
[TBL] [Abstract][Full Text] [Related]
50. Biochemical pharmacology and resistance to 2-chloro-2'-arabino-fluoro-2'-deoxyadenosine, a novel analogue of cladribine in human leukemic cells.
Lotfi K; Månsson E; Spasokoukotskaja T; Pettersson B; Liliemark J; Peterson C; Eriksson S; Albertioni F
Clin Cancer Res; 1999 Sep; 5(9):2438-44. PubMed ID: 10499616
[TBL] [Abstract][Full Text] [Related]
51. Targeting lipid metabolism by the lipoprotein lipase inhibitor orlistat results in apoptosis of B-cell chronic lymphocytic leukemia cells.
Pallasch CP; Schwamb J; Königs S; Schulz A; Debey S; Kofler D; Schultze JL; Hallek M; Ultsch A; Wendtner CM
Leukemia; 2008 Mar; 22(3):585-92. PubMed ID: 18079738
[TBL] [Abstract][Full Text] [Related]
52. Bryostatin induces protein kinase C modulation, Mcl-1 up-regulation and phosphorylation of Bcl-2 resulting in cellular differentiation and resistance to drug-induced apoptosis in B-cell chronic lymphocytic leukemia cells.
Thomas A; Pepper C; Hoy T; Bentley P
Leuk Lymphoma; 2004 May; 45(5):997-1008. PubMed ID: 15291360
[TBL] [Abstract][Full Text] [Related]
53. [Effect of 2-chlorodeoxyadenosine, arabinoside cytosine and doxorubicin on acute myeloid leukemia clonogenic cell proliferation].
Sawiński K; Hansz J; Kozłowska-Skrzypczak M
Acta Haematol Pol; 1995; 26(3):279-84. PubMed ID: 8525773
[TBL] [Abstract][Full Text] [Related]
54. 2-Chlorodeoxyadenosine (CdA) for patients with previously untreated chronic lymphocytic leukemia (CLL).
Delannoy A; Martiat P; Gala JL; Deneys V; Ferrant A; Bosly A; Schieff JM; Michaux JL
Leukemia; 1995 Jul; 9(7):1130-5. PubMed ID: 7630184
[TBL] [Abstract][Full Text] [Related]
55. Intracellular pharmacokinetics of 2-chlorodeoxyadenosine in leukemia cells from patients with chronic lymphocytic leukemia.
Alessi-Severini S; Gati WP; Belch AR; Paterson AR
Leukemia; 1995 Oct; 9(10):1674-9. PubMed ID: 7564508
[TBL] [Abstract][Full Text] [Related]
56. 2-chlorodeoxyadenosine (cladribine) induced allergic cutaneous reactions with eosinophilia in a patient with B-cell chronic lymphocytic leukemia.
Robak T; Sysa-Jedrzejowska A; Robak E; Dabkowski J; Blasinska-Morawiec M
J Med; 1997; 28(3-4):199-209. PubMed ID: 9355024
[TBL] [Abstract][Full Text] [Related]
57. Bryostatin 1-induced modulation of the acute lymphoblastic leukemia cell line Reh.
al-Katib A; Mohammad RM; Khan K; Dan ME; Pettit GR; Sensenbrenner LL
J Immunother Emphasis Tumor Immunol; 1993 Jul; 14(1):33-42. PubMed ID: 8399068
[TBL] [Abstract][Full Text] [Related]
58. Mitoxantrone in combination with an inhibitor of DNA-dependent protein kinase: a potential therapy for high risk B-cell chronic lymphocytic leukaemia.
Elliott SL; Crawford C; Mulligan E; Summerfield G; Newton P; Wallis J; Mainou-Fowler T; Evans P; Bedwell C; Durkacz BW; Willmore E
Br J Haematol; 2011 Jan; 152(1):61-71. PubMed ID: 21083655
[TBL] [Abstract][Full Text] [Related]
59. Phenomena of spontaneous proliferation, differentiation, and apoptosis in primary culture of leukemic lymphocytes.
Kalvelyté A; Pabrézaité L
Exp Cell Res; 1994 Apr; 211(2):344-52. PubMed ID: 8143782
[TBL] [Abstract][Full Text] [Related]
60. Is there a place for 2-CDA in the treatment of B-CLL?
Mitterbauer M; Hilgenfeld E; Wilfing A; Jäger U; Knauf WU
Leukemia; 1997 Apr; 11 Suppl 2():S35-7. PubMed ID: 9178836
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]